David J. Ramsay Entrepreneur of the Year

Allan Doctor bio

Allan Doctor, MD

University of Maryland School of Medicine
Professor, Department of Pediatrics
Director, Center for Blood Oxygen Transport and Hemostasis

Dr. Doctor is a pediatric intensivist and nationally recognized physician-scientist who led the Pediatric Critical Care Division at Washington University and St. Louis Children’s Hospital for 10 years before transitioning to UMB in 2019 to focus on a rapidly expanding research program and the development of a novel biosynthetic artificial red cell.

Dr. Doctor’s laboratory studies the role of red blood cell-based signaling in the control of regional blood flow, related pathophysiology arising from acquired red cell injuries, blood substitute design, and translational transfusion medicine in critical illness. He directs the School of Medicine’s Center for Blood Oxygen Transport and Hemostasis, which works to advance the development of an artificial blood product for use in rural areas or trauma settings such as battlefields that don’t have easy access to donated blood for transfusions.

In 2016, Dr. Doctor co-founded KaloCyte, Inc., to commercialize ErythroMer, a dried, bio-inspired artificial red blood cell based on his research. He served as KaloCyte’s first president and is currently chief scientific officer. KaloCyte, which is supported by nearly $10 million in federal grants and investor funding, moved from St. Louis to Baltimore along with Dr. Doctor in 2019. It employs eight staff members at Health Sciences Research Facility III and collaborates extensively with UMB on federally sponsored grants.

Dr. Doctor earned his bachelor’s degree in neurobiology and his medical degree from the University of Virginia. After a residency in emergency medicine at the University of Pittsburgh, he went to Boston Children’s Hospital and completed additional residency training in pediatrics as well as fellowships in pediatric emergency medicine and critical care.